An Adult Spasticity Registry of OnabotulinumtoxinA Treatment

Trial Profile

An Adult Spasticity Registry of OnabotulinumtoxinA Treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Muscle spasticity
  • Focus Therapeutic Use
  • Acronyms ASPIRE
  • Sponsors Allergan
  • Most Recent Events

    • 20 Apr 2018 According to an Allergan media release, data from this trial will be presented at the 70th Annual American Academy of Neurology (AAN) Meeting 2018.
    • 11 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 20 Jul 2017 Planned End Date changed from 1 Sep 2017 to 11 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top